Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-21-006127
Filing Date
2021-02-11
Accepted
2021-02-11 21:29:54
Documents
1
Period of Report
2021-02-11

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 3577
  Complete submission text file 0000899243-21-006127.txt   5187
Mailing Address WALKER HOUSE 87 MARY STREET GEORGE TOWN E9 KY1-9001
Business Address WALKER HOUSE 87 MARY STREET GEORGE TOWN E9 KY1-9001 212.300.5575
Casdin Partners Master Fund, L.P. (Reporting) CIK: 0001534265 (see all company filings)

State of Incorp.: E9 | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-40030 | Film No.: 21622232

Mailing Address 1325 BOYLSTON STREET SUITE 500 BOSTON MA 02215
Business Address 1325 BOYLSTON STREET SUITE 500 BOSTON MA 02215 617-370-8701
Decibel Therapeutics, Inc. (Issuer) CIK: 0001656536 (see all company filings)

EIN.: 464198709 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations